West Author Logo

Graham Reynolds

VP & GM, Global Biologics

一月 18, 2012

Reynolds to Speak at Drug Delivery Partnerships Conference

West’s Graham Reynolds will present “An Integrated Approach to Biologic Drug Delivery Systems: Meeting the needs of the patient, and optimizing drug product performance,” at the Drug Delivery Partnerships meeting in Las Vegas, on January 25, 2012.

Graham will speak at a session entitled “Maximize the potential of your drug delivery system through drug device combination products,” chaired by Phil Green, Senior Director Drug Delivery Devices at Merck.

The presentation will focus on the importance of considering four key elements of an integrated drug delivery system and the critical interfaces between them. These four elements are:

  • The patient: All aspects of the system are designed to bring benefit to the patient
  • The drug: The drug molecule remains critical; however, the presentation will highlight the value of ensuring that the drug containment system and the delivery device provide the appropriate therapy or treatment
  • The container: While the container is critical to ensuring drug stability and integrity, considering interface options with the device may help to optimize the overall system
  • The device: As the use of devices grows, drug companies are considering device selection at an earlier phase, recognizing that it can impact market position and treatment effectiveness

West is uniquely positioned to understand and support this need, combining leadership in drug containment systems with device development and manufacturing expertise, and a network of industry partnerships aimed at ensuring optimum packaging and delivery systems for today’s sophisticated drug products. Examples of solutions will be briefly discussed, including Daikyo Crystal Zenith® containment systems and the SmartDose® electronic patch injector, which is an ideal example of an integrated packaging and delivery system that meets a growing market need.

Graham Reynolds
VP & GM, Global Biologics
610 594 2935

West markets SmartDose® as a multi-component system only. Final assembly of the prefilled component is completed by the pharmaceutical company. SmartDose® is a registered trademark of Medimop Medical Projects Ltd., a subsidiary of West Pharmaceutical Services, Inc.

Daikyo Crystal Zenith® is a registered trademark of Daikyo Seiko, Ltd. Daikyo Crystal Zenith technology is licensed from Daikyo Seiko, Ltd.

Recommended Blogs